Nearly half of all treatment-eligible patients infected with chronic hepatitis B do not receive treatment for the disease, a new study has found.
The investigators said the research was bolstered by the large, ethnically diverse multicenter cohort that formed the foundation of the analysis.
“We know that hepatitis B is predominantly a disease affecting ethnic minorities, as well as underserved and vulnerable populations,” said Robert Wong, MD, MS, of the Veterans Affairs Palo Alto